UNC-Chapel Hill receives $65 million from NIH for antiviral drug development center
The new center will develop antivirals that could combat future pandemic-level viruses.
Source: unc.edu
Stay updated with breaking news from Nathaniel Moorman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new center will develop antivirals that could combat future pandemic-level viruses.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19.